Trial Profile
Glycemic Control With Insulin Glargine Plus Insulin Glulisine Versus Premixed Insulin Analogues in Real-World Practices: A Cost-Effectiveness Study With a Randomized Pragmatic Trial Design.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 10 Aug 2011
Price :
$35
*
At a glance
- Drugs Insulin glargine (Primary) ; Insulin glulisine (Primary) ; Insulin aspart/insulin protamine aspart; Insulin neutral protamine lispro/insulin lispro
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 29 Jun 2011 Results published in Clinical Therapeutics.
- 05 Nov 2010 New trial record.